Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes gene-editing future - AD HOC NEWS
Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes gene-editing future AD HOC NEWS
Vertex Pharma stock (US92532F1003): cystic fibrosis leader eyes gene-editing future AD HOC NEWS
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.